BACKGROUND:
One of the common and alarming problems to the patients is keloid formation that may occur after skin injury. Keloid had many cosmetic psychological and functional outcome, Multiple treatment have been present but still the treatment of keloid scar is dilemma due to lack of effective and excellent method .
AIM OF STUDY:
To evaluate the use of intralesional BTX-A for treatment of keloid scar.
PATIENTS AND METHODS:
Between October 2018 to January 2020, 20 patients presented to us with history of keloid in different parts of their body, those patients received intralesional BTX-A injection and they were followed up for one year and evaluated by scar score system.
RESULTS:
Our result showed that 10 patients had good response according to scar score, 7 patients had fair, 1 excellent and 2 patient had no improvement.no local and systemic side effect was seen.
CONCLUSION:
The use of BTX-A for treatment of keloids has shown to be effective in control and treatment of keloid and can be a part of treatment modalities
|
- Ahuja RB, Chatterjee P. Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids. Burn,2014; 40:58-8.
- Smith OJ, MCgrouther DA. The natural history and spontaneous resolution of keloid scars, Journal of plastic, Reconstructure and Asthestic surgery, 2014;67:87-92.
- George Broguton , Rod J. Roohrich. Wound and scars selected reading in plastic surgery, 2005;10:1-56.
- Micheal L. Bentz Bruce S. Bauer, Ranald M. Zaker. Principles and practice of pediatric plastic surgery 2nd edition, Thieme,2016;104.
- Jill Sorch, Jan Rice. Reconstructure plastic surgical nursing; Clinical management and wound care, 1st Blackwell Publishing, 2005:177.
- Maria Z. Simionom, Marita Eisenmann-Klein. Plastic and reconstructure surgery,1st Springer,2010:8.
- Xia Zhibo, Zhang Miaoboo. Intralestional botulinum toxin type A injection as a new measure for keloid plastic and reconstructure surgery, 2009;124:275e-279e.
- Parid A. Sherris, Holgar G. Gassuer. Botulmnue toxin to minimize facial scaring. Facial plastic surgery, 2002;18:35-39.
- Gerd G. Gauglitz. Management of keloid and hypertrophic scars: current and emerging options. Clinical, cosmetic and investigational dermatology, 2013;6:103-14.
- Zhibo Xia,Fengmin Zhang, Weibin Lin, Miaobo Zhang, Ying Lin, effect of botulinum toxin type A or transforming growth factors β1 in fibroblast derived from hypertrophic scar: a preliminary report. AethPlastSurg, 2010;34:424-27.
- Zhibo Xiao, Miaobo Zhang, Ying Lin, LihhonyRen.Botuliunm Toxin type A inhibits connective tissue growth factor expression in fibroblasts derived from hypertrophic scar. Aesthplastsurg, 2011;35:802-7.
- Dominigue Batifol et al. Treatment of keloid scar by botulinum toxin. Journal of ear, nose and throat disorder, 2017;2:1024.
- Uyesugi B, Lippincott B, Daves. Treatment of painful keloid with botulinum toxin type A. AmJphys Med Rehabil, 2010; 89:153-55.
- Zhibo Xiao, Fengmin Zhang, Ziwei Cui. Treatment of hypertrophic scar with intralesionalbotulinum toxin type A injection: A preliminary report. Aesthplastsurg, 2009; 33:409-12.
- Xia Zhibo, Zhang Miaobo.Intralesionalbotulinum toxin type A injection as a new treatment measure for keloid. Plastic and reconstructive surgery, 2009;124:253e-79e.
|
